Reneo Pharmaceuticals to Present Preclinical Mavodelpar Data at the Society for Inherited Metabolic Disorders Annual Meeting 2023

RPHMDelisted Stock  USD 18.20  1.40  8.33%   
About 55% of Reneo Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Reneo Pharmaceuticals suggests that some traders are interested regarding Reneo Pharmaceuticals' prospects. Reneo Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Reneo Pharmaceuticals. Many technical investors use Reneo Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
IRVINE, Calif., March 09, 2023 -- Reneo Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare

Read at benzinga.com
benzinga news
  

Reneo Pharmaceuticals Fundamental Analysis

We analyze Reneo Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reneo Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reneo Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Reneo Pharmaceuticals is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Reneo Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reneo Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reneo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reneo Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Reneo Pharmaceuticals Related Equities

CNSPCns Pharmaceuticals   10.00   
0%
100.0%
IMMXImmix Biopharma   6.67   
0%
66.0%
PRMEPrime Medicine,   6.52   
0%
65.0%
CELCCelcuity LLC   5.81   
0%
58.0%
HOWLWerewolf Therapeutics   3.25   
0%
32.0%
KRONKronos Bio   2.17   
0%
21.0%
HEPAHepion Pharmaceuticals   2.04   
0%
20.0%
OCEAOcean Biomedical   1.79   
0%
17.0%
VIRVir Biotechnology   0.95   
0%
9.0%
RPRXRoyalty Pharma   0.55   
0%
5.0%
NKTXNkarta   0.41   
4.0%
0%
APLSApellis Pharmaceuticals   0.85   
8.0%
0%
LEGNLegend Biotech   0.88   
8.0%
0%
ADPTAdaptive Biotechnologies   2.33   
23.0%
0%
KZRKezar Life   2.92   
29.0%
0%
EWTXEdgewise Therapeutics   3.10   
31.0%
0%
CCCCC4 Therapeutics   5.25   
52.0%
0%
DNAGinkgo Bioworks   5.48   
54.0%
0%
SMMTSummit Therapeutics   5.55   
55.0%
0%
CGEMCullinan Oncology   6.82   
68.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Reneo Stock

If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device